These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19542904)

  • 21. Artifactually elevated serum-free thyroxine levels measured by equilibrium dialysis in a pregnant woman with familial dysalbuminemic hyperthyroxinemia.
    Hoshikawa S; Mori K; Kaise N; Nakagawa Y; Ito S; Yoshida K
    Thyroid; 2004 Feb; 14(2):155-60. PubMed ID: 15068631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
    Slyper AH; Shaker JL
    Clin Pediatr (Phila); 1993 Feb; 32(2):121-3. PubMed ID: 8094332
    [No Abstract]   [Full Text] [Related]  

  • 23. Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation.
    Kaluarachchi DC; Colaizy TT; Pesce LM; Tansey M; Klein JM
    J Perinatol; 2017 Mar; 37(3):277-282. PubMed ID: 27906195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rate of recalls in congenital hypothyroidism based upon a regional survey in Isfahan, Iran, using serum T4 and TSH analyses: comparison of two different recall methods.
    Amini M; Hashemipour M; Iranpour R; Hovsepian S; Haghighi S; Khatibi K
    Horm Res; 2005; 64(6):287-92. PubMed ID: 16269871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal screening for congenital hypothyroidism in West Black Sea area, Turkey.
    Simsek E; Karabay M; Kocabay K
    Int J Clin Pract; 2005 Mar; 59(3):336-41. PubMed ID: 15857333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial dysalbuminemic hyperthyroxinemia in pregnancy.
    Sachmechi I; Schussler GC
    Eur J Endocrinol; 1995 Dec; 133(6):729-31. PubMed ID: 8548059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program.
    Lanting CI; van Tijn DA; Loeber JG; Vulsma T; de Vijlder JJ; Verkerk PH
    Pediatrics; 2005 Jul; 116(1):168-73. PubMed ID: 15995048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed.
    Kempers MJ; van Tijn DA; van Trotsenburg AS; de Vijlder JJ; Wiedijk BM; Vulsma T
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5851-7. PubMed ID: 14671180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy insight: management of Graves' disease during pregnancy.
    Chan GW; Mandel SJ
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A screening programme for congenital hypothyroidism: preliminary results.
    Sadler WA; Lynskey C; Brownlie BE; Mortimer JG; Buckfield P; McArthur JE; Easton DM
    N Z Med J; 1979 Aug; 90(642):143-5. PubMed ID: 290922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iodinated contrast in pregnant women and neonatal thyroid function].
    Chauvet P; Terral D; Colombier M; Mulliez A; Suarez C; Brunhes A; Gallot D
    Gynecol Obstet Fertil; 2016 Dec; 44(12):685-689. PubMed ID: 27839713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of the screening program for congenital hypothyroidism in Berlin (1978-1995).
    Grüters A; Liesenkötter KP; Zapico M; Jenner A; Dütting C; Pfeiffer E; Lehmkuhl U
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():28-31. PubMed ID: 9439911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroxine-Based Screening for Congenital Hypothyroidism in Neonates with Down Syndrome.
    Erlichman I; Mimouni FB; Erlichman M; Schimmel MS
    J Pediatr; 2016 Jun; 173():165-8. PubMed ID: 26995701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of newborns of mothers with Graves' disease.
    Levy-Shraga Y; Tamir-Hostovsky L; Boyko V; Lerner-Geva L; Pinhas-Hamiel O
    Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot Neonatal Screening Program for Central Congenital Hypothyroidism: Evidence of Significant Detection.
    Braslavsky D; Méndez MV; Prieto L; Keselman A; Enacan R; Gruñeiro-Papendieck L; Jullien N; Savenau A; Reynaud R; Brue T; Bergadá I; Chiesa A
    Horm Res Paediatr; 2017; 88(3-4):274-280. PubMed ID: 28898885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent cutoff values in screening newborns for hypothyroidism.
    Lott JA; Sardovia-Iyer M; Speakman KS; Lee KK
    Clin Biochem; 2004 Sep; 37(9):791-7. PubMed ID: 15329318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroxine (T4) immunoassay using a filter paper blood samples for screening of neonates for hypothyroidism.
    Larsen PR; Broskin K
    Pediatr Res; 1975 Jul; 9(7):604-9. PubMed ID: 1161349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic effectiveness of simultaneous thyroxine and thyroid-stimulating hormone screening measurements. Thirteen years' experience in the Northeast Italian Screening Programme.
    Zamboni G; Zaffanello M; Rigon F; Radetti G; Gaudino R; Tatò L
    J Med Screen; 2004; 11(1):8-10. PubMed ID: 15006107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.